Clintec, the global service Contract Research Organisation (CRO) has been awarded the Queen's Award for Enterprise 2017 in the category of International Trade for a second time.

The Queen's Award, the highest accolade that can be granted to any business operating within the UK, recognises outstanding corporate achievement.

Clintec was selected from amongst some of the top performing UK businesses for its differentiated geographical capability and impressive growth in the mid-market of the contract research sector.

Dr. Rabinder Buttar, Founder and CEO of Clintec said, "We are honoured to have received the Queen's Award for Enterprise again as we celebrate 20 years of global success in clinical research. The people of Clintec are very excited and energised to grow the business further and continue to deliver excellent clinical research solutions to our clients, several of whom have partnered with us for many years"

"The United Kingdom has served as a great base from which we have expanded into over 50 countries and we would like to thank all people in the UK and worldwide who have supported us along our incredible journey", he added

Clintec's extensive global reach throughout Western Europe, Central and Eastern Europe, Middle East and North Africa, Sub-Saharan Africa, Asia Pacific and North America, provides access to both developed and emerging markets, and all to the global clinical and ethical standards required for high-quality drug development.

The company partners with many of the world¹s global pharmaceutical companies, as well as smaller biotechnology companies, to fast-track their product development using innovative and flexible outsourcing solutions underpinned with an entrepreneurial and client-centric approach.